Delayed
Nasdaq Stockholm
06:03:20 2024-07-03 am EDT
|
5-day change
|
1st Jan Change
|
0.235
SEK
|
-1.26%
|
|
+6.58%
|
-76.26%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
106.4
|
672.8
|
1,213
|
627.2
|
264.4
|
155.1
|
-
|
-
|
Enterprise Value (EV)
1 |
86.99
|
517.8
|
974.9
|
471.9
|
206.5
|
47.05
|
120.1
|
181.1
|
P/E ratio
|
-1.13
x
|
-7.77
x
|
-14.7
x
|
-8.1
x
|
-2.75
x
|
-0.79
x
|
-0.79
x
|
-0.79
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
21.7
x
|
96.1
x
|
176
x
|
90.9
x
|
24.9
x
|
8.71
x
|
4.43
x
|
2.28
x
|
EV / Revenue
|
17.8
x
|
74
x
|
141
x
|
68.4
x
|
19.5
x
|
2.64
x
|
3.43
x
|
2.66
x
|
EV / EBITDA
|
-1.41
x
|
-9.04
x
|
-15.7
x
|
-6.74
x
|
-2.35
x
|
-0.73
x
|
-1.91
x
|
-2.92
x
|
EV / FCF
|
-1.34
x
|
-8.82
x
|
-16.3
x
|
-5.85
x
|
-2.19
x
|
-0.63
x
|
-1.64
x
|
-2.55
x
|
FCF Yield
|
-74.4%
|
-11.3%
|
-6.13%
|
-17.1%
|
-45.7%
|
-159%
|
-60.8%
|
-39.2%
|
Price to Book
|
2.57
x
|
3.99
x
|
4.79
x
|
3.53
x
|
3.14
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
90,931
|
222,041
|
266,540
|
266,912
|
267,065
|
651,478
|
-
|
-
|
Reference price
2 |
1.170
|
3.030
|
4.550
|
2.350
|
0.9900
|
0.2380
|
0.2380
|
0.2380
|
Announcement Date
|
2/7/20
|
2/19/21
|
2/11/22
|
2/17/23
|
2/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4.9
|
7
|
6.9
|
6.9
|
10.6
|
17.8
|
35
|
68
|
EBITDA
1 |
-61.5
|
-57.3
|
-62
|
-70
|
-88
|
-64.2
|
-63
|
-62
|
EBIT
1 |
-68.9
|
-64.9
|
-69.4
|
-77
|
-96.7
|
-69.6
|
-69
|
-67
|
Operating Margin
|
-1,406.12%
|
-927.14%
|
-1,005.8%
|
-1,115.94%
|
-912.26%
|
-391.01%
|
-197.14%
|
-98.53%
|
Earnings before Tax (EBT)
1 |
-69.8
|
-63.9
|
-69.2
|
-77.2
|
-94.6
|
-69
|
-69
|
-67
|
Net income
1 |
-69.8
|
-63.9
|
-69.3
|
-77.3
|
-94.8
|
-69
|
-69
|
-67
|
Net margin
|
-1,424.49%
|
-912.86%
|
-1,004.35%
|
-1,120.29%
|
-894.34%
|
-387.64%
|
-197.14%
|
-98.53%
|
EPS
2 |
-1.040
|
-0.3900
|
-0.3100
|
-0.2900
|
-0.3600
|
-0.3000
|
-0.3000
|
-0.3000
|
Free Cash Flow
1 |
-64.7
|
-58.7
|
-59.8
|
-80.7
|
-94.3
|
-75
|
-73
|
-71
|
FCF margin
|
-1,320.41%
|
-838.57%
|
-866.67%
|
-1,169.57%
|
-889.62%
|
-421.35%
|
-208.57%
|
-104.41%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/7/20
|
2/19/21
|
2/11/22
|
2/17/23
|
2/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
1.6
|
1.9
|
-
|
2
|
2.5
|
4.7
|
-
|
3.2
|
4
|
3.8
|
4.7
|
6.2
|
EBITDA
1 |
-14.5
|
-17.6
|
-
|
-22.3
|
-21.2
|
-27.7
|
-17.3
|
-21.7
|
-18.5
|
-15.3
|
-14.9
|
-15.5
|
EBIT
1 |
-16.3
|
-19.4
|
-
|
-
|
-23.1
|
-
|
-
|
-24
|
-20.6
|
-16.7
|
-16.2
|
-16.9
|
Operating Margin
|
-1,018.75%
|
-1,021.05%
|
-
|
-
|
-924%
|
-
|
-
|
-750%
|
-515%
|
-439.47%
|
-344.68%
|
-272.58%
|
Earnings before Tax (EBT)
|
-16.4
|
-19.3
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-16.4
|
-19.4
|
-17.8
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-1,025%
|
-1,021.05%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-0.0700
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/29/22
|
7/15/22
|
11/16/22
|
2/17/23
|
4/28/23
|
7/14/23
|
10/27/23
|
2/9/24
|
4/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
26
|
Net Cash position
1 |
19.4
|
155
|
238
|
155
|
57.9
|
108
|
35
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.4194
x
|
Free Cash Flow
1 |
-64.7
|
-58.7
|
-59.8
|
-80.7
|
-94.3
|
-75
|
-73
|
-71
|
ROE (net income / shareholders' equity)
|
-162%
|
-60.6%
|
-32.8%
|
-35.9%
|
-72.3%
|
-62%
|
-65%
|
-155%
|
ROA (Net income/ Total Assets)
|
-124%
|
-52.6%
|
-30.4%
|
-33%
|
-83.9%
|
-
|
-
|
-
|
Assets
1 |
56.2
|
121.5
|
228
|
233.9
|
113
|
-
|
-
|
-
|
Book Value Per Share
|
0.4600
|
0.7600
|
0.9500
|
0.6700
|
0.3200
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
5.5
|
4.6
|
0.1
|
-
|
-
|
-
|
1
|
1
|
Capex / Sales
|
112.24%
|
65.71%
|
1.45%
|
-
|
-
|
-
|
2.86%
|
1.47%
|
Announcement Date
|
2/7/20
|
2/19/21
|
2/11/22
|
2/17/23
|
2/9/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -76.57% | 14.6M | | +11.63% | 127B | | -8.76% | 10.76B | | -18.88% | 7.06B | | +49.68% | 6.5B | | -34.01% | 3.99B | | +8.39% | 3.44B | | -20.19% | 2.45B | | -19.41% | 1.89B | | -20.90% | 1.75B |
Medical Devices & Implants
|